Stockreport

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China [Yahoo! Finance]

Adlai Nortye Ltd. - American Depositary Shares  (ANL) 
PDF Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it has entered into an exclusive licensi [Read more]